Clinical Trials List
Protocol Number2020-03-005A
Not yet recruiting
2022-02-01 - 2025-06-30
Others
Terminated1
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Ling-Ming Tseng Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- 林可瀚 Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
64 participants
-
Global
0 participants
